Take Limited
NSE: TAKE · Healthcare Research, Analytics & Technology · sector
₹10.39NSE close 2026-10-26
Key numbers
Market cap₹154 cr
Price₹10.39
52w high / low₹50 / ₹10
P/E12.1xSector median 27.9x
P/B5.0xSector median 3.0x
Book value₹2.1
Dividend yield–Sector median 0.34%
ROE49.8%Sector median 6.1%
ROCE20.1%Sector median 9.8%
OPM-2.0%Sector median 8.4%
Debt / equity0.00xSector median 0.01x
EV/EBITDA–Sector median 14.8x
Interest cover35.7x
Current ratio4.54x
Sales growth 3y-34.1%Sector median +7.2%
Profit growth 3y–Sector median -13.6%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 9 companies in Healthcare Research, Analytics & Technology (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 35.7x in the last 12 months.
- 22.27% of the promoters' shares are pledged (0.0% of all shares).
- Promoter holding fell by 5.19 percentage points in a year, to 0.00% (2026-09-30).
- Operating cash flow was below net profit in 2 of the last 5 years (FY26, FY25).
- Net loss in 3 of the last 8 quarters.
- Other income was 62% of net profit in the last 12 months.
- Debtor days went from 39 (FY24) to 1 (FY26).
- No dividend in the last 5 financial years.
- Price ₹10.39 on 2026-10-26: -79.3% from the 52-week high, 0.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹49.16 · low ₹7.37
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 54 | 30 |
| EBITDA | -1 | -3 | -1 | -1 | -0 | -0 | -1 | -0 |
| OPM % | – | – | – | – | – | – | -1.5% | -0.9% |
| Other income | 0 | 9 | 2 | 0 | 0 | 1 | 5 | 1 |
| Net profit | -2 | 48 | -5 | -1 | 6 | 1 | 4 | 1 |
| EPS (₹) | -0.11 | 3.26 | -0.33 | -0.06 | 0.43 | 0.07 | 0.29 | 0.07 |
| Revenue YoY | – | – | – | – | ||||
| Profit YoY | – | -97.7% | – | – |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 655 | 189 | 66 | 0 | 54 | 85 |
| EBITDA | 7 | -29 | -107 | -7 | -2 | -2 |
| Net profit | -782 | -100 | -120 | 37 | 11 | 13 |
| EPS (₹) | -53.50 | -6.86 | -8.18 | 2.56 | 0.74 | 0.86 |
| Revenue growth | -71.1% | -65.3% | -100.0% | – | – | |
| Profit growth | – | – | – | -71.0% | -68.2% | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -34.1% | -41.2% | – |
| Net profit | – | – | -68.2% |
| EPS | – | – | – |
| Share price | – | -20.5% (2y) | -49.8% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 109 | -9 | 21 | 31 |
| Borrowings | – | 33 | 28 | 0 | 0 |
| Cash & equivalents | – | 11 | 1 | 3 | 0 |
| Total assets | – | 224 | 88 | 36 | 36 |
| Fixed assets | – | 8 | 22 | 0 | 0 |
| Capital work in progress | – | 10 | – | 0 | – |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 30 | 7 | 0 | 0 |
| Inventory | – | 1 | 1 | 0 | 0 |
| Payables | – | 24 | 17 | 1 | 1 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 30 | 20 | 9 | -16 | -4 |
| Cash from investing | -31 | -2 | -7 | 22 | 2 |
| Cash from financing | -55 | -36 | -12 | -3 | -1 |
| Capex | 31 | 8 | 8 | 0 | 0 |
| Free cash flow | -2 | 12 | 1 | -16 | -4 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | -92.3% | 1,348.1% | 182.5% | 35.0% |
| ROCE % | – | -26.7% | -591.9% | 13.1% | 15.4% |
| Debtor days | – | 58 | 39 | – | 1 |
| Inventory days | – | 3 | 12 | – | 0 |
| Payable days | – | 104 | 260 | – | 9 |
| Cash conversion cycle (days) | – | -43 | -209 | – | -8 |
| Working capital days | – | -21 | -300 | – | 125 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 0.00% |
| FIIs | 0.21% |
| DIIs | 0.00% |
| of which Mutual funds | 0.00% |
| Public (non-institutions) | 99.79% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 53.41% | 53.41% | 53.34% | 5.19% | 0.00% | 0.00% | 0.00% | 0.00% |
| Promoter group | % |
|---|---|
| Srinivasan H R | 0.00% |
| Aakanksha Management Consultancy and Holdings Private Limited | 0.00% |
| Esyspro Infotech Limited | 0.00% |
| Asia Global Trading(Chennai) Private Limited | 0.00% |
| Take Solutions Pte Limited | 0.00% |
| Public holders above 1% | % |
|---|---|
| Akarshika Traders LLP | 10.87% |
| Whamia Traders LLP | 7.02% |
| Vaishali Commosales LLP | 5.77% |
| Moonlight Multitrade LLP | 5.38% |
| Rukhmani Garments LLP | 5.31% |
| Zuber Trading LLP | 5.04% |
| Sarvagay Textile | 4.82% |
| Avance Ventures Private Limited | 3.83% |
| Empower Tradex Private Limited | 3.35% |
| Nikhilesh Traders LLP | 3.15% |
| Alia Commosales LLP | 2.71% |
| Sadbhav Minerals Private Limited | 2.32% |
| The North Consulting | 1.16% |
63,302 shareholders. Pledged: 22.27% of promoter shares.
Peers in Healthcare Research, Analytics & Technology
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SYNGENE | ₹14,527 cr | 65.4x | 3.0x | 4.6% | 7.0% | 19.8% | +5.4% | 0.35% |
| INDGN | ₹14,472 cr | 36.0x | 4.6x | 13.9% | 17.4% | 16.2% | – | 0.33% |
| SUVEN | ₹6,917 cr | – | 11.7x | -100.5% | -59.5% | -4,155.5% | -19.3% | – |
| VIMTALABS | ₹2,185 cr | 27.4x | 4.8x | 19.1% | 23.5% | 34.3% | +8.9% | 0.20% |
| BI | ₹189 cr | 4.3x | 1.0x | 2.3% | 7.0% | 8.4% | +274.4% | – |
| TAKE | ₹154 cr | 12.1x | 5.0x | 49.8% | 20.1% | -2.0% | -34.1% | – |
| NOVELIX | ₹141 cr | 31.7x | 3.0x | 11.3% | 8.8% | 3.1% | +411.3% | – |
| JSTL | ₹102 cr | 28.5x | 1.4x | 6.1% | 9.8% | 20.5% | +19.4% | 0.97% |
| ADESHWAR | ₹23 cr | 18.0x | 0.9x | 5.5% | 10.2% | 4.9% | -12.0% | – |
All 9 companies in Healthcare Research, Analytics & Technology →
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2024-08-07 | Other | Annual General Meeting |
| 2023-08-07 | Other | Annual General Meeting |
| 2022-12-15 | Other | Annual General Meeting |
| 2021-08-02 | Other | Annual General Meeting |
| 2020-09-17 | Other | Annual General Meeting |
| 2019-08-01 | Dividend | Dividend - Re 0.40 Per Share |
| 2019-02-22 | Dividend | Interim Dividend - Re 0.30 Per Share |
| 2018-11-09 | Dividend | Interim Dividend - Re 0.30 Per Share |
| 2018-08-02 | Dividend | Annual General Meeting/Final Dividend- Re 0.40 Per Share/ Special Dividend- Re 0.60 Per Share (Purpose Revised) |
| 2018-02-15 | Dividend | Interim Dividend Re 0.30 Per Share (Purpose Revised) |
| 2017-11-17 | Dividend | Interim Dividend - Re 0.30 Per Share |
| 2017-08-03 | Dividend | Dividend - Re 0.40/- Per Share |
| 2017-02-16 | Dividend | Interim Dividend Re 0.30 Per Share |
| 2016-11-17 | Dividend | Interim Dividend - Re 0.30 Per Share |
| 2016-08-18 | Dividend | Annual General Meeting/ Dividend - Re 0.40/- Per Share |
| 2016-02-17 | Dividend | Interim Dividend- Re 0.30/- Per Share |
| 2015-11-23 | Dividend | Interim Dividend - Re 0.30/- Per Share |
| 2015-08-20 | Dividend | Annual General Meeting/ Dividend - Re 0.40/- Per Share |
| 2015-02-18 | Dividend | Interim Dividend - Re 0.30/- Per Share |
| 2014-11-25 | Dividend | Interim Dividend - Re 0.30/- Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Healthcare Research, Analytics & Technology |
| Sub-industry | Healthcare Research, Analytics & Technology |
| Symbol | TAKE |
| BSE code | 532890 |
| ISIN | INE142I01023 |
| Face value | ₹1.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.